NEDD9 promotes oncogenic signaling in mammary tumor development

Cancer Research

Volumn 69, Issue 18, 2009, Pages 7198-7206

  Izumchenko, Eugene ^a,c   Singh, Mahendra K ^a   Plotnikova, Olga V ^a,d   Tikhmyanova, Nadezhda ^a,b   Little, Joy L ^a   Serebriiskii, Ilya G ^a   Seo, Sachiko ^e   Kurokawa, Mineo ^e   Egleston, Brian L ^a   Klein Szanto, Andres ^a   Pugacheva, Elena N ^f   Hardy, Richard R ^a   Wolfson, Marina ^c   Connolly, Denise C ^a   Golemis, Erica A ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^e UNIVERSITY OF TOKYO   (Japan)

^f WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; PROTEIN NEDD9; PROTEIN TYROSINE KINASE; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER GROWTH; CARCINOGENESIS; CELL INFILTRATION; CELL MIGRATION; CELL SPREADING; CELL SURVIVAL; CONTROLLED STUDY; GENE ACTIVATION; GENETIC MODEL; IMMUNOCOMPETENT CELL; MAMMARY GLAND; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; SOLID TUMOR;

ANIMALS; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FOCAL ADHESION KINASE 1; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, INBRED C57BL; PROTEINS; SIGNAL TRANSDUCTION;

EID: 70349747017     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-0795     Document Type: Article

References (51)

1. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000;406:747-752
2. Rugo HS. The importance of distant metastases in hormone-sensitive breast cancer. Breast 2008;17 Suppl 1:S3-8.
3. Lahlou H, Sanguin-Gendreau V, Zuo D, et al. Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression. Proc Natl Acad Sci U S A 2007;104:20302-20307
4. Maroulakou IG, Oemler W, Naber SP, Tsichlis PN. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice. Cancer Res 2007;67:167-177 (Pubitemid 46142772)
5. Ursini-Siegel J, Hardy WR, Zuo D, et al. ShcA signalling is essential for tumour progression in mouse models of human breast cancer. EMBO J 2008;27:910-920
6. 4 Integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 2006;126:489-502.
7. Cas-like docking protein, associates with FAK, and induces pseudohyphal growth in yeast. Mol Cell Biol 1996;16:3327-3337
8. Minegishi M, Tachibana K, Sato T, Iwata S, Nojima Y, Morimoto C. Structure and function of Cas-L, a 105-kD Crk-associated substrate-related protein that is involved in β-1 integrin-mediated signaling in lymphocytes. J Exp Med 1996;184:1365-1375 (Pubitemid 26354693)
9. O'Neill GM, Golemis EA. Proteolysis of the docking protein HEF1 and implications for focal adhesion dynamics. Mol Cell Biol 2001;21:5094-5108
10. O'Neill GM, Seo S, Serebriiskii IG, Lessin SR, Golemis EA. A new central scaffold for metastasis: parsing HEF1/Cas-L/NEDD9. Cancer Res 2007;67:8975-8979 (Pubitemid 47535876)
11. 1 integrin dependent migration through an HEF1 effector pathway. Eur J Immunol 2001;31:1417-1427
12. Fashena SJ, Einarson MB, O'Neill GM, Patriotis CP, Golemis EA. Dissection of HEF1-dependent functions in motility and transcriptional regulation. J Cell Sci 2002;115:99-111. (Pubitemid 34105533)
13. Sanz-Moreno V, Gadea G, Ahn J, et al. Rac activation and inactivation control plasticity of tumor cell movement. Cell 2008;135:510-523
14. Kim M, Gans JD, Nogueira C, et al. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 2006;125:1269-1281 (Pubitemid 43949521)
15. Natarajan M, Stewart JE, Golemis EA, et al. HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells. Oncogene 2006;25:1721-1732
16. Ji H, Ramsey MR, Hayes DN, et al. LKB1 modulates lung cancer differentiation and metastasis. Nature 2007;448:807-810 (Pubitemid 47266337)
17. Law SF, Zhang Y-Z, Klein-Szanto A, Golemis EA. Cell-cycle regulated processing of HEF1 to multiple protein forms differentially targeted to multiple compartments. Mol Cell Biol 1998;18:3540-3551 (Pubitemid 28240526)
18. Nagashima T, Oyama M, Kozuka-Hata H, Yumoto N, Sakaki Y, Hatakeyama M. Phosphoproteome and transcriptome analyses of ErbB ligand-stimulated MCF-7 cells. Cancer Genomics Proteomics 2008;5:161-168 (Pubitemid 351957307)
19. Simpson KJ, Selfors LM, Bui J, et al. Identification of genes that regulate epithelial cell migration using an siRNA screening approach. Nat Cell Biol 2008;10:1027-1038
20. Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung. Nature 2005;436:518-524
21. Nathke IS. The adenomatous polyposis coli protein: the Achilles heel of the gut epithelium. Annu Rev Cell Dev Biol 2004;20:337-366 (Pubitemid 39488642)
22. Seo S, Asai T, Saito T, et al. Crk-associated substrate lymphocyte type is required for lymphocyte trafficking and marginal zone B cell maintenance. J Immunol 2005;175:3492-3501 (Pubitemid 41292006)
23. Dilworth SM. Polyoma virus middle T antigen and its role in identifying cancer-related molecules. Nat Rev Cancer 2002;2:951-956
24. Lin EY, Jones JG, Li P, et al. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol 2003;163:2113-2126 (Pubitemid 37310040)
25. Desai KV, Xiao N, Wang W, et al. Initiating oncogenic event determines gene-expression patterns of human breast cancer models. Proc Natl Acad Sci U S A 2002;99:6967-6972 (Pubitemid 34526241)
26. Guy CT, Cardiff RD, Muller WJ. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 1992;12:954-961
27. Ruppert D, Wand MP, Carroll RJ. Semiparametric regression. New York: Cambridge University Press; 2003.
28. Shults J, Ratcliffe SJ, Leonard M. Improved generalized estimating equation analysis via xtqls for quasileast squares in STATA. STATA J 2007;7:147-166
29. Harrell FE. Chapter 2. Regression modeling strategies. New York: Springer; 2001.
30. Pugacheva EN, Golemis EA. The focal adhesion scaffolding protein HEF1 regulates activation of the Aurora-A and Nek2 kinases at the centrosome. Nat Cell Biol 2005;7:937-946
31. Tang H, Hao Q, Fitzgerald T, Sasaki T, Landon EJ, Inagami T. Pyk2/CAKβ tyrosine kinase activity-mediated angiogenesis of pulmonary vascular endothelial cells. J Biol Chem 2002;277:5441-5447 (Pubitemid 34968592)
32. O'Neill GM, Fashena SJ, Golemis EA. Integrin signaling: a new Cas(t) of characters enters the stage. Trends Cell Biol 2000;10:111-119 (Pubitemid 30110694)
33. Law SF, Zhang Y-Z, Fashena S, Toby G, Estojak J, Golemis EA. Dimerization of the docking/adaptor protein HEF1 via a carboxy-terminal helix-loop-helix domain. Exp Cell Res 1999;252:224-235 (Pubitemid 29485141)
34. Blake RA, Broome MA, Liu X, et al. SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol Cell Biol 2000;20:9018-9027 (Pubitemid 32245931)
35. Alessi DR, James SR, Downes CP, et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα. Curr Biol 1997;7:261-269 (Pubitemid 27176852)
36. Toker A, Newton AC. Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site. J Biol Chem 2000;275:8271-8274 (Pubitemid 30180163)
37. Nakamoto T, Seo S, Sakai R, et al. Expression and tyrosine phosphorylation of Crk-associated substrate lymphocyte type (Cas-L) protein in human neutrophils. J Cell Biochem 2008;105:121-128
38. Cas and the Cas-like protein, p105HEF1. J Biol Chem 1997;272:19719-19730
39. Singh MK, Dadke D, Nicolas E, et al. A novel Cas family member, HEPL, regulates FAK and cell spreading. Mol Biol Cell 2008;19:1627-1636 (Pubitemid 351805115)
40. Ishino M, Ohba T, Sasaki H, Sasaki T. Molecular cloning of a cDNA encoding a phosphoprotein, Efs, which contains a Src homology 3 domain and associates with Fyn. Oncogene 1995;11:2331-2338 (Pubitemid 26008410)
41. Pylayeva Y, Gillen KM, Gerald W, Beggs HE, Reichardt LF, Giancotti FG. Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J Clin Invest 2009;119:252-266
42. Versteeg HH, Schaffner F, Kerver M, et al. Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice. Cancer Res 2008;68:7219-7227
43. Cuevas BD, Winter-Vann AM, Johnson NL, Johnson GL. MEKK1 controls matrix degradation and tumor cell dissemination during metastasis of polyoma middle-T driven mammary cancer. Oncogene 2006;25:4998-5010.
44. Lopez JI, Camenisch TD, Stevens MV, Sands BJ, McDonald J, Schroeder JA. CD44 attenuates metastatic invasion during breast cancer progression. Cancer Res 2005;65:6755-6763 (Pubitemid 41060713)
45. Liu X, Elia AEH, Law SF, Golemis EA, Farley J, Wang T. A novel ability of Smad3 to regulate proteasomal degradation of a Cas family member, HEF1. EMBO J 2000;19:6759-6769 (Pubitemid 32011669)
46. Singh M, Cowell L, Seo S, O'Neill G, Golemis E. Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle. Cell Biochem Biophys 2007;48:54-72. (Pubitemid 47345633)
47. Law SF, O'Neill GM, Fashena SJ, Einarson MB, Golemis EA. The docking protein HEF1 is an apoptotic mediator at focal adhesion sites. Mol Cell Biol 2000;20:5184-5195
48. Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cancer Res 2006;66:4672-4680
49. Honda H, Oda H, Nakamoto T, et al. Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas. Nat Genet 1998;19:361-365 (Pubitemid 28357908)
50. Friedman A, Perrimon N. Genetic screening for signal transduction in the era of network biology. Cell 2007;128:225-231 (Pubitemid 46123521)
51. Pugacheva EN, Golemis EA. HEF1-aurora A interactions: points of dialog between the cell cycle and cell attachment signaling networks. Cell Cycle 2006;5:384-391